Topotecan - GlaxoSmithKline
At a glance
- Drug Originator GlaxoSmithKline
- Drug Licenced by Merck Pharmaceuticals UK; Nippon Kayaku
- Drug Class Antineoplastics; Camptothecins; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
- USA Patent Applicants SANDOZ
- USA Patents 3
- NDAs 2
- Patent Applications 7,710
Table of Contents
Disclaimer